Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Recruiting 11Completed 6Not yet recruiting 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 2INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gynecologic 2Breast 2Lymphoid 1Genitourinary 1

Conditions

Breast Neoplasms 681Neoplasms 593Carcinoma, Non-Small-Cell Lung 292Colorectal Neoplasms 291Prostatic Neoplasms 284Lung Neoplasms 224Melanoma 161Multiple Myeloma 151Neoplasm Metastasis 145Pancreatic Neoplasms 143Head and Neck Neoplasms 143Ovarian Neoplasms 136Carcinoma, Hepatocellular 126Leukemia, Myeloid, Acute 122Colonic Neoplasms 114Brain Neoplasms 113Squamous Cell Carcinoma of Head and Neck 111Uterine Cervical Neoplasms 109Stomach Neoplasms 104Lymphoma 101Recurrence 100Glioblastoma 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 83Lymphoma, Non-Hodgkin 82Urinary Bladder Neoplasms 78Lymphoma, Follicular 78Hematologic Neoplasms 78Glioma 75Parkinson Disease 4, Autosomal Dominant Lewy Body 73Sarcoma 72

Interventions

Magnetic Resonance Imaging 2Electrocardiography 2Diphenhydramine 2Acetaminophen 2fludarabine phosphate 1fludarabine 1durvalumab 1aldesleukin 1Tomography, X-Ray Computed 1Respiratory Function Tests 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Meperidine 1Mastectomy, Subcutaneous 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Hydroxyzine 1Histamine Antagonists 1Granisetron 1Droperidol 1Doxylamine 1Diphenoxylate 1Cystoscopy 1Cyclophosphamide 1Codeine 1Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Carcinoma in Situ × 1 year × Clear all
NCT02311959 2026-04-14

MAPAM-01

Institut Claudius Regaud

Phase 3 Completed
450 enrolled
Breast

Breast Neoplasms, Carcinoma in Situ

NCT06056843 2026-04-03

PUD

International Agency for Research on Cancer

Phase NA Completed
150 enrolled
Breast

Breast Neoplasms, Carcinoma in Situ

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
15 enrolled 21 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT06263582 2025-08-19

Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
12 enrolled 18 charts
GynecologicLymphoid

Carcinoma in Situ, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Lymphoma, Follicular

NCT04368247 2025-08-07

Skin Fluorescent Imaging (SFI) System in Patients With Nevi

Orlucent, Inc

Completed
300 enrolled

Carcinoma in Situ, Dysplastic Nevus Syndrome, Nevus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡